.jpg "Hospital Build Asia 2012 Exhibition & Congress")
Influenza Congress USA 2010
Innovation and oppportunity for pharma, biotechs, healthcare and investorsNov 08,2010 - Nov 10,2010
Hilton Embassy Row, Washington, United States
-
Highlights
Influenza Congress USA is THE annual influenza conference in North America addressing every aspect of influenza policy and planning, influenza research & development and stakeholder partnerships.
The influenza vaccine is the fastest growing segment in the adult vaccine market. Annually, more than 3.5 million people die of influenza. By 2016, this market is expected to grow to $4.4 billion. H1N1 remains the most immediate threat. In the US, President Obama responded by earmarking $1.8 billion to fight the swine flu.No one knows the amount of damage the H1N1 outbreak may cause during Fall in the Northern Hemisphere. Governments & international organizations are clamoring for effective vaccines & antivirals to protect their populations. In recent years, influenza vaccine development & alternative treatments like antivirals have evolved tremendously as pharma & biotech companies work hard to develop new technology & alternative methods from traditional egg-based vaccines. The key drivers impacting the development of influenza vaccines & related therapies include cost effectiveness, capacity & adaptability.The US accounts for over 50% of the global vaccine market. With so much talent & innovation taking place & heightened concern due to the global swine flu pandemic, Influenza Congress USA is both timely & necessary.
Event Reminder
- Registration Open
- Call for Papers
- Call for Speakers
- Receive GTM eblast updates
- Security Code:
Event Profile
- Theme: Innovation and oppportunity for pharma, biotechs, healthcare and investors
Contact Details
- Contact person: Michael Weinberg
- Event website: http://www.terrapinn.com/2010/usaflu/
- Phone: 212 379 6320
- Fax: 212 379 6319
Tags
Contact Organizer
